AMLX Stock Soars as Amylyx GLP-1 Drug Succeeds in Late-Stage Trial
finance.yahoo.com
18.08.2026 22:10
57 views
Related stories
You can’t rely on the S&P 500 as much as you may think
marketwatch.com · 29.10
Lilly raises outlook for third time this year as Zepbound sales soar
marketwatch.com · 29.10
The Fed held off on a rate hike. Today’s GDP and inflation reports could make waiting harder.
marketwatch.com · 29.10
China’s leaders vow tougher corruption crackdown
ft.com · 29.10
Medicare used AI to pre-approve patient care, and it immediately led to a large drop in medical services
marketwatch.com · 29.10
The countries making a fortune from the US-China rivalry
economist.com · 29.10